Summit X LLC’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-640
| Closed | -$1K | – | 266 |
|
|
2022
Q3 | $1K | Sell |
640
-200
| -24% | -$313 | ﹤0.01% | 246 |
|
|
2022
Q2 | $5K | Hold |
840
| – | – | ﹤0.01% | 243 |
|
|
2022
Q1 | $10K | Buy |
840
+250
| +42% | +$2.98K | ﹤0.01% | 253 |
|
|
2021
Q4 | $11K | Sell |
590
-175
| -23% | -$3.26K | ﹤0.01% | 258 |
|
|
2021
Q3 | $21K | Hold |
765
| – | – | 0.01% | 258 |
|
|
2021
Q2 | $17K | Sell |
765
-300
| -28% | -$6.67K | ﹤0.01% | 263 |
|
|
2021
Q1 | $24K | Sell |
1,065
-485
| -31% | -$10.9K | 0.01% | 260 |
|
|
2020
Q4 | $20K | Sell |
1,550
-600
| -28% | -$7.74K | 0.01% | 246 |
|
|
2020
Q3 | $9 | Buy |
2,150
+250
| +13% | +$1 | ﹤0.01% | 438 |
|
|
2020
Q2 | $22K | Buy |
1,900
+200
| +12% | +$2.32K | 0.01% | 206 |
|
|
2020
Q1 | $19K | Buy |
1,700
+50
| +3% | +$559 | 0.01% | 184 |
|
|
2019
Q4 | $20K | Buy |
1,650
+700
| +74% | +$8.49K | 0.01% | 225 |
|
|
2019
Q3 | $19K | Buy |
+950
| New | +$19K | 0.01% | 225 |
|